| 1 |
34741718 | The expression and clinical significance of ERβ/ERα in ovarian cancer: can we predict the effectiveness of platinum plus taxane therapy? | 2021 Nov 6 |
1 |
| 2 |
31327134 | Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer Society. | 2020 Jan |
3 |
| 3 |
30833575 | Pocket similarity identifies selective estrogen receptor modulators as microtubule modulators at the taxane site. | 2019 Mar 4 |
3 |
| 4 |
31209809 | Prognostic Factors for Luminal B-like Breast Cancer. | 2019 Jun |
1 |
| 5 |
30397885 | Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis. | 2018 Sep |
1 |
| 6 |
26712520 | Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K. | 2016 Jan 1 |
2 |
| 7 |
25997855 | Characterization of Durable Responder for Capecitabine Monotherapy in Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer. | 2015 Oct |
1 |
| 8 |
26257973 | A Case of Docetaxel Induced Myositis and Review of the Literature. | 2015 |
1 |
| 9 |
25047707 | Systematically defining single-gene determinants of response to neoadjuvant chemotherapy reveals specific biomarkers. | 2014 Sep 15 |
2 |
| 10 |
24072219 | DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes. | 2013 |
1 |
| 11 |
24649129 | Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer. | 2013 Jan |
1 |
| 12 |
21340479 | Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint. | 2012 Jan |
2 |
| 13 |
22866081 | Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy. | 2011 Mar |
2 |
| 14 |
20579400 | The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells. | 2010 |
1 |
| 15 |
17293601 | Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. | 2007 May |
6 |
| 16 |
17404087 | Microtubule-associated protein-tau is a bifunctional predictor of endocrine sensitivity and chemotherapy resistance in estrogen receptor-positive breast cancer. | 2007 Apr 1 |
1 |
| 17 |
15685822 | Adjuvant chemotherapy for early-stage breast cancer: the tAnGo trial. | 2004 Dec |
3 |